Patients only become candidates for this breast cancer therapy after a specific biomarker test, but the brand couldn’t see which oncologists were ordering it. In this case study, discover how Skipta and the NorstellaLinQ real-world data foundation identified the oncologists at the gateway to treatment, and how the brand can now message testers and non-testers differently.